Measuring the uptake and impact of chlamydia screening programs-easier said than done

Sexually Transmitted Diseases

Volumn 39, Issue 2, 2012, Pages 89-91

  Chow, Joan M ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; FUNDING; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LAW; REVIEW; SCREENING;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; MASS SCREENING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PELVIC INFLAMMATORY DISEASE; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH; UNITED STATES; YOUNG ADULT;

EID: 84855838991     PISSN: 01485717     EISSN: 15374521     Source Type: Journal    
DOI: 10.1097/OLQ.0b013e318245f95c     Document Type: Review

References (22)

1. Koh HK, Sebelius KG. Promoting prevention through the Affordable Care Act. N Engl J Med 2010; 363:1296-1299.
2. Maciosek MV, Edwards NM, Coffield AB, et al. Priorities among effective clinical preventive services: methods. Am J Prev Med 2006; 31:90-96. (Pubitemid 43956596)
3. Sexually Transmitted Diseases Testing in California-2007 Clinical Laboratory Survey Summary. Accessed October 16, 2011, at http://www.cdph.ca.gov/ data/statistics/Documents/STD-Data-LabSurvey.pdf.
4. Sexually Transmitted Disease Laboratory Testing Practices Among United States Public Health Laboratories in 2007. Accessed September 19, 2011, at http://www.cdc.gov/std/general/labsurveyreport-2011.pdf.
5. Centers for Disease Control and Prevention. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. MMWR 2009; 58:362-365.
6. Heijne JC, Althaus C, Herzog S, et al. Estimating the rate of annual chlamydia screening uptake in US women. Abstract 01-S01.05. In: International Society for Sexually Transmitted Disease Research; 2011 July 10-13; Quebec City, Canada: Sex Transm Infect 2011 p.Suppl 1: A22.
7. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance, 2009. Atlanta, GA: U.S. Department of Health and Human Services; 2010 December.
8. Sexually Transmitted Disease Surveillance 2009 Supplement-Chlamydia Prevalence Monitoring Project Annual Report. US Department of Health and Human Services, 2010. Accessed April 26, 2011, at http://www.cdc.gov/std/ Chlamydia2009/default.htm.
9. Fine D, Dicker L, Mosure D, et al. Increasing chlamydia positivity in women screened in family planning clinics: do we know why? Sex Transm Dis 2008; 35:47-52. (Pubitemid 351619352)
10. Satterwhite CL, Tian LH, Braxton J, et al. Chlamydia prevalence among women and men entering the National Job Training Program: United States, 2003-2007. Sex Transm Dis 2010; 37: 63-67.
11. Datta SD, Kruszon-Moran D, Berman S, et al. Chlamydia trachomatis trends in the United States among persons 14 to 39 years of age, 1999-2008. Sex Transm Dis 2012; 39:92-96.
12. Brunham RC, Pourbohloul B, Mak S, et al. The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection. J Infect Dis 2005; 192:1836-1844. (Pubitemid 41587838)
13. Brunham RC, Rekart ML. The arrested immunity hypothesis and the epidemiology of chlamydia control. Sex Transm Dis 2008; 35:53-54. (Pubitemid 351619350)
14. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996; 334:1362-1366. (Pubitemid 26152715)
15. Ostergaard L, Andersen B, Moller JK, et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000; 31:951-957. (Pubitemid 32299353)
16. Oakeshott P, Kerry S, Aghaizu A, et al. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. BMJ 2010; 340:c1642.
17. Owusu-Edusei K Jr, Bohm MK, Chesson HW, et al. Chlamydia screening and pelvic inflammatory disease: insights from exploratory time-series analyses. Am J Prev Med 2010; 38:652-627.
18. Bohm MK, Newman L, Satterwhite CL, et al. Pelvic inflammatory disease among privately insured women, United States, 2001-2005. Sex Transm Dis 2010; 37:131-136.
19. Scholes D, Satterwhite CL, Yu O, et al. Long-term trends in Chlamydia trachomatis and related outcomes in a US managed care population. Sex Transm Dis 2012; 39:81-88.
20. Suijkerbuijk AW, van den Broek IV, Brouwer HJ, et al. Usefulness of primary care electronic networks to assess the incidence of chlamydia, diagnosed by general practitioners. BMC Fam Pract 2011; 12:72.
21. Saleeby E, Brindis CD. Women, reproductive health, and health reform. JAMA 2012; 306:1256-1257.
22. Hoover K, Tao G, Body B, et al. Suboptimal repeat testing of women with positive chlamydia tests in the USA, 2008-2010. Abstract O1-S01.04. In: International Society for Sexually Transmitted Disease Research; 2011 July 10-13; Quebec City, Canada: Sex Transm Infect; 2011.p.Suppl 1: A22.